FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA. (June 2017) - Martin, P.; Jung, S.; Pitcher, B.; Bartlett, N.L.; Blum, K.A.; Shea, T.; Ruan, J.; Smith, S.E.; Leonard, J.P.; Cheson, B.D.